tiprankstipranks
Spero Therapeutics (SPRO)
NASDAQ:SPRO
US Market
SPRO
Spero Therapeutics
RESEARCH TOOLSreports
Want to see SPRO full AI Analyst Report?

Spero Therapeutics (SPRO) Income Statement

585 Followers

Spero Therapeutics Income Statement

Last quarter (Q1 2026), Spero Therapeutics's total revenue was $258.00K, a decrease of -95.61% from the same quarter last year. In Q1, Spero Therapeutics's net income was $-7.20M. See Spero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 59.62M$ 47.98M$ 103.78M$ 48.58M$ 3.07M
Gross Profit
$ 59.62M$ -48.78M$ 52.34M$ 48.58M$ 3.07M
Operating Expenses
$ 59.64M$ 24.58M$ 30.86M$ 90.78M$ 91.04M
Depreciation and Amortization
$ 0.00$ 2.00K$ 367.00K$ 869.00K$ 646.00K
EBITDA
$ -24.00K$ -72.48M$ 27.15M$ -42.94M$ -87.17M
Operating Income
$ -24.00K$ -73.36M$ 21.48M$ -42.20M$ -87.97M
Other Income/Expenses
$ 8.86M$ 4.79M$ 3.92M$ -4.22M$ -1.78M
Pretax Income
$ 8.83M$ -68.57M$ 25.40M$ -46.41M$ -89.76M
Net Income
$ 8.57M$ -68.57M$ 22.81M$ -46.41M$ -89.76M
Per Share Metrics
Basic EPS
$ 0.15$ -1.27$ 0.43$ -1.23$ -2.91
Diluted EPS
$ 0.15$ -1.27$ 0.43$ -1.23$ -2.91
Weighted Average Shares Outstanding
 56.02M 54.04M 52.70M 37.59M 30.90M
Weighted Average Shares Outstanding (Diluted)
 59.04M 54.04M 52.99M 37.59M 30.90M
Currency in USD

Spero Therapeutics Earnings and Revenue History